SCHEMBL6647939

SCHEMBL6647939

CCCc1ccncc1-c1nc(-c2cc(C(F)(F)F)cc(C(F)(F)F)c2)cs1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SREBF2 Q12772 7/20 0.41
CTSS P25774 1/20 0.41
CTSK P43235 1/20 0.41
CYP19A1 P11511 3/20 0.40
CDK5 Q00535 1/20 0.40
CDK5R1 Q15078 1/20 0.40
L3MBTL1 Q9Y468 3/20 0.39
KDM4E B2RXH2 3/20 0.39
MEN1 O00255 1/20 0.39
KMT2A Q03164 1/20 0.39
NPSR1 Q6W5P4 1/20 0.39
EIF4E P06730 1/20 0.39
MAPT P10636 3/20 0.39
ATM Q13315 3/20 0.39
ALDH1A1 P00352 1/20 0.39
CYP1A2 P05177 2/20 0.39
CYP2E1 P05181 2/20 0.39
CYP3A4 P08684 2/20 0.39
CYP2C8 P10632 2/20 0.39
CYP2D6 P10635 2/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6628971 0.89 KDM4E (0.51) SREBF2CYP19A1CDK5CDK5R1L3MBTL1
SCHEMBL6648508 0.84 KDM4E (0.51) SREBF2CYP19A1L3MBTL1KDM4EKMT2A
SCHEMBL6650983 0.83 CYP19A1 (0.49) CYP19A1CDK5CDK5R1L3MBTL1KDM4E
SCHEMBL6626251 0.81 KDM4E (0.52) CYP19A1CDK5CDK5R1L3MBTL1KDM4E
SCHEMBL6649838 0.81 KDM4E (0.59) SREBF2CYP19A1L3MBTL1KDM4EMAPT
SCHEMBL6646344 0.80 KDM4E (0.57) SREBF2CYP19A1KDM4EMEN1KMT2A
SCHEMBL6647943 0.80 KDM4E (0.43) CYP19A1CDK5CDK5R1L3MBTL1KDM4E
SCHEMBL6649845 0.80 RAB9A (0.59) SREBF2CYP19A1L3MBTL1KDM4EMAPT
SCHEMBL6649722 0.80 SREBF2 (0.46) SREBF2CYP19A1KDM4EMEN1KMT2A
SCHEMBL6648190 0.79 KDM4E (0.52) SREBF2CYP19A1KDM4EMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1432706-A2 3-PYRIDYL OR 4-ISOQUINOLINYL THIAZOLES AS C17,20 LYASE INHIBITORS Bayer Pharmaceuticals Corporation (US) 2004-06-30 EP disclosed
WO-2003027085-A2 3-PYRIDYL OR 4-ISOQUINOLINYL THIAZOLES AS C17,20 LYASE INHIBITORS BAYER PHARMACEUTICALS CORPORATION (US) 2003-04-03 WO disclosed